5 results match your criteria: "Unit of Tata Memorial Centre Mumbai[Affiliation]"

An Innovative Technique of Microsurgical Training on Fresh "Chicken Quarter" Model: Our Experience.

Indian J Plast Surg

June 2023

Dr B. Borooah Cancer Institute, A Grant-in-aid Institute of Department of Atomic Energy, Govt. of India and a Unit of Tata Memorial Centre-Mumbai, Guwahati, Assam, India.

 Regular practice, quality clinical exposure, and academic discussion are essential in any surgical specialty training. This study discusses and validates the option of using a fresh "chicken quarter" model with a measurable scoring system, as a standard training regimen in microvascular surgery. This can be a very effective, economical, and easily accessible model for residents.

View Article and Find Full Text PDF

An Early Experience of Microvascular Surgery in a Tertiary Cancer Centre in North East India.

World J Plast Surg

March 2022

Dept. of Plastic Surgery, Dr B. Borooah Cancer Institute, A Grant-in-Aid Institute of Dept. of Atomic Energy, Govt. of India and a Unit of Tata Memorial Centre-Mumbai. Guwahati, Assam, India.

Background: Microvascular surgery is a highly technique sensitive and evolving speciality in reconstructive oncosurgery. There is a definite learning curve associated with it. In this case series, we describe our initial experience in microvascular surgery at a tertiary cancer centre in North East India.

View Article and Find Full Text PDF

An Experience of Scalp Island Flap Based on the Posterior Branch of the Superficial Temporal Artery for Patients with Mucormycosis and Cancer.

Indian J Otolaryngol Head Neck Surg

October 2022

Dr B. Borooah Cancer Institute, A Grant-in-Aid Institute of Dept. of Atomic Energy, Govt. of India and a unit of Tata Memorial Centre-Mumbai, Guwahati, Assam 781016 India.

To find out the utility of the scalp flap based on the posterior branch of the superficial temporal artery in patients with head and neck mucormycosis and malignancy. This was a multi-institutional observational study conducted at a tertiary cancer centre in North East India and a super-speciality hospital in Maharashtra from January 2021 to June 2021. Patients with malignancy and mucormycosis were only considered.

View Article and Find Full Text PDF

Background: Oesophageal cancer both squamous cell [SCC] and adenocarcinoma have poor outcomes with high morbidity and mortality. Our hospital-based registry for year 2017-2018 showed that oesophageal cancer constituted 22.7% of annual case load.

View Article and Find Full Text PDF